Edouard J. Trabulsi

Thomas Jefferson University — United States

Medicine · Health Sciences

45h-index8.0kcitations433works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(161), Prostate Cancer Treatment and Research(144), Bladder and Urothelial Cancer Treatments(88), Urinary and Genital Oncology Studies(41), Renal cell carcinoma treatment(36)

Publications431 total

Abstract C134: Trends in prostate cancer disparities among diverse populations in Philadelphia
Cancer Epidemiology Biomarkers & Prevention·2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte–Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin–Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer
The Journal of Urology·2025· 2 citedOpen Access
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry
JCO Precision Oncology·2025Open Access
Feasibility of Contrast-Enhanced Ultrasound Fusion With Pretreatment MR/CT for Recurrence Detection in Renal Cell Carcinoma Patients During Post-Ablation Surveillance
Ultrasound in Medicine & Biology·2025· 2 citedOpen Access
A non-DRE, voided urine, genomic assay to diagnose prostate cancer and to assess its aggressiveness.
Journal of Clinical Oncology·2025
Non-DRE Voided Urine Test to Diagnose Prostate Cancer: Updated Results
Diagnostics·2025Open Access
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
Journal of Clinical Oncology·2025· 29 cited
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates
JCO Precision Oncology·2024· 2 citedOpen Access
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
BJUI Compass·2024· 3 citedOpen Access
MP74-20 VPAC TARGETED DIAGNOSTIC OPTICAL IMAGING ASSAY (VPAC ASSAY) FOR PROSTATE CANCER
The Journal of Urology·2024
Risk of Secondary Malignancies After Pelvic Radiation: A Population-based Analysis
European Urology Open Science·2024· 12 citedOpen Access
Abstract 1031: Targeting genomic biomarker in voided urine for prostate cancer detection
Cancer Research·2024
Optimum Imaging Strategies for Advanced Prostate Cancer Guideline
2024
Complications and Influential Perioperative Factors Associated with SpaceOAR Hydrogel Placement
Advances in Urology·2024· 3 citedOpen Access
Optical Imaging with a biological vector for diagnosis of oncologic diseases
Nuclear Medicine and Biology·2023
Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men
Prostate Cancer and Prostatic Diseases·2023· 5 cited
VPAC targeted optical imaging assay (VPAC assay) of voided urine for management of patients with persistently elevated PSA.
JCO Global Oncology·2023Open Access
Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative
Urologic Oncology Seminars and Original Investigations·2023· 8 citedOpen Access
Enhancing bladder cancer care through the multidisciplinary clinic approach.
PubMed·2023· 5 cited
Supplementary Table 2 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
page 1 of 22Next →

Frequent Co-authors

Leonard G. Gomella(27), Costas D. Lallas(22), Adam P. Dicker(17), Peter A. McCue(11), Robert B. Den(10), Jean Hoffman‐Censits(8), William Kevin Kelly(7), Karen E. Knudsen(7), Timothy N. Showalter(7), Felix Y. Feng(6), R. Jeffrey Karnes(6), Kasra Yousefi(6), Elai Davicioni(6), David Y.T. Chen(5), Howard M. Sandler(5), Matthew J. Schiewer(5), Benjamin E. Leiby(5), Elizabeth R. Plimack(4), Daniel W. Lin(4), Mark Hurwitz(4)